Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Corteva Agriscience is managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. All of these pending matters are concentrated under 1 distinct examiner, MITCHELL, EDWIN COLEMAN, and are located within 1 distinct art unit. This level of concentration means that the company's current prosecution success relies on the interactions with this single examiner.
As the busiest examiner, MITCHELL, EDWIN COLEMAN is responsible for 2 pending office actions. This alignment between the 2 pending office actions and the busiest examiner's workload indicates a unified prosecution front. Practitioners can focus their strategy on the specific tendencies of this 1 distinct examiner and 1 distinct art unit.
The presence of 1 distinct examiner for the pending workload suggests a consistent dialogue with the USPTO. While this reduces the complexity of managing different examiner styles, it also increases the impact of any single examiner's perspective on the Biotechnology & Pharmaceuticals portfolio. The applicant's progress is currently dependent on navigating the specific requirements of this individual within their assigned art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MITCHELL, EDWIN COLEMAN | 2 | 32.1% | +65.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17045204 | WEED CONTROL FROM APPLICATIONS OF PYRIDINE CARBOXYLIC ACID HERBICIDES AND 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE (HPPD) INHIBITORS | MITCHELL, EDWIN COLEMAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17045188 | WEED CONTROL FROM APPLICATIONS OF PYRIDINE CARBOXYLIC ACID HERBICIDES AND ACETYL CoA CARBOXYLASE (ACCase) INHIBITORS | MITCHELL, EDWIN COLEMAN | — |
| 17045204 | WEED CONTROL FROM APPLICATIONS OF PYRIDINE CARBOXYLIC ACID HERBICIDES AND 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE (HPPD) INHIBITORS | MITCHELL, EDWIN COLEMAN | — |
| Art Unit | Apps |
|---|---|
| 1619 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17045188 | WEED CONTROL FROM APPLICATIONS OF PYRIDINE CARBOXYLIC ACID HERBICIDES AND ACETYL CoA CARBOXYLASE (ACCase) INHIBITORS | MITCHELL, EDWIN COLEMAN | 1619 | §103DP | Final Rejection | — | Pending | Oct 05, 2020 |
| 17045204 | WEED CONTROL FROM APPLICATIONS OF PYRIDINE CARBOXYLIC ACID HERBICIDES AND 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE (HPPD) INHIBITORS | MITCHELL, EDWIN COLEMAN | 1619 | §103§112Other | Final Rejection | — | Pending | Oct 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCorteva Agriscience has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Edwin Coleman Mitchell has the most, with 2 of Corteva Agriscience's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
